SCHEMBL1034038

SCHEMBL1034038

CCOC(=O)COc1ccc(C(=O)CCc2sc3ccccc3c2C)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.46
F9 P00740 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
CASP3 P42574 1/20 0.41
CASP7 P55210 1/20 0.41
CASP9 P55211 1/20 0.41
ALDH1A1 P00352 4/20 0.40
ESR1 P03372 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 3/20 0.40
F10 P00742 1/20 0.40
CNR2 P34972 2/20 0.39
KMT2A Q03164 3/20 0.38
NOD2 Q9HC29 1/20 0.38
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
CYP1A2 P05177 1/20 0.38
LMNA P02545 2/20 0.37
MITF O75030 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031807 0.89 CYP1A2 (0.45) L3MBTL1KDM4EKMT2ACYP1A2
SCHEMBL1034264 0.85 ESR1 (0.43) ABCB1F9ESR1
SCHEMBL1034041 0.85 ESR1 (0.43) ABCB1F9ESR1
SCHEMBL1034852 0.83 FBP1 (0.41) ALDH1A1MAPTCNR2KMT2ANOD2
SCHEMBL1035257 0.79 PTPN7 (0.44) ALDH1A1KDM4ECNR2CYP1A2
SCHEMBL1035525 0.79 CYP1A2 (0.45) L3MBTL1ALDH1A1KDM4EGAAMAPT
SCHEMBL1031595 0.75 ESR1 (0.40) ABCB1F9ESR1
SCHEMBL1035193 0.74 PPARD (0.47)
SCHEMBL1032851 0.74 PPARD (0.47)
SCHEMBL15543999 0.73 ABCB1 (0.53) ABCB1L3MBTL1CASP3CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD ABCB1 3776/4885F9 2858/4885L3MBTL1 2525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.